相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Health disparities in chronic liver disease
Ani Kardashian et al.
HEPATOLOGY (2023)
Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease
Zoi Michailidou et al.
JOURNAL OF INNATE IMMUNITY (2022)
Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist
Brett E. Phillips et al.
CARDIOVASCULAR DIABETOLOGY (2022)
Activation of Liver mTORC1 Protects Against NASH via Dual Regulation of VLDL-TAG Secretion and De Novo Lipogenesis
Kahealani Uehara et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2022)
Cellular and Molecular Mechanisms of Metformin Action
Traci E. LaMoia et al.
ENDOCRINE REVIEWS (2021)
Short-term overnutrition induces white adipose tissue insulin resistance through sn-1,2-diacylglycerol/PKC epsilon/insulin receptor Thr(1160) phosphorylation
Kun Lyu et al.
JCI INSIGHT (2021)
Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH
Leigh Goedeke et al.
MOLECULAR METABOLISM (2021)
IL-6 Receptor Blockade Increases Circulating Adiponectin Levels in People with Obesity: An Explanatory Analysis
Stephan Wueest et al.
METABOLITES (2021)
Improved postprandial glucose metabolism in type 2 diabetes by the dual glucagon-like peptide-1/glucagon receptor agonist SAR425899 in comparison with liraglutide
Michele Schiavon et al.
DIABETES OBESITY & METABOLISM (2021)
Liver-targeting drugs and their effect on blood glucose and hepatic lipids
Amalia Gastaldelli et al.
DIABETOLOGIA (2021)
Associations Among Adipose Tissue Immunology, Inflammation, Exosomes and Insulin Sensitivity in People With Obesity and Nonalcoholic Fatty Liver Disease
Anja Fuchs et al.
GASTROENTEROLOGY (2021)
Enhanced Palmitate-Induced Interleukin-8 Formation in Human Macrophages by Insulin or Prostaglandin E2
Janin Henkel et al.
BIOMEDICINES (2021)
Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans
Kalliopi Pafili et al.
MOLECULAR METABOLISM (2021)
Beyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology
Sara Della Torre
CELLS (2021)
CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling
Vanessa Castelli et al.
CELLS (2021)
Regulation of mTORC1 by amino acids in mammalian cells: A general picture of recent advances
Shizhe Zhang et al.
ANIMAL NUTRITION (2021)
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail
Mithun Sharma et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2021)
Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial
Sabine Kahl et al.
DIABETES CARE (2020)
Elafibranor: a potential drug for the treatment of nonalcoholic steatohepatitis (NASH)
Menso J. Westerouen Van Meeteren et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2020)
Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index
Maki Tobari et al.
GUT AND LIVER (2020)
Leukocyte Heterogeneity in Adipose Tissue, Including in Obesity
Ada Weinstock et al.
CIRCULATION RESEARCH (2020)
Multi-layered epigenetic regulation of IRS2 expression in the liver of obese individuals with type 2 diabetes
Christin Krause et al.
DIABETOLOGIA (2020)
Effect of saroglitazar 2 mg and 4 mg on glycemic control, lipid profile and cardiovascular disease risk in patients with type 2 diabetes mellitus: a 56-week, randomized, double blind, phase 3 study (PRESS XII study)
Manjunath Krishnappa et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Metabolic liver disease in diabetes - From mechanisms to clinical trials
Bedair Dewidar et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2020)
A Membrane-Bound Diacylglycerol Species Induces PKC epsilon-Mediated Hepatic Insulin Resistance
Kun Lyu et al.
CELL METABOLISM (2020)
Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications
Carol Wysham et al.
POSTGRADUATE MEDICINE (2020)
Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease
Laurie L. Baggio et al.
MOLECULAR METABOLISM (2020)
Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling
Sara Della Torre
FRONTIERS IN ENDOCRINOLOGY (2020)
The Selective Peroxisome Proliferator-Activated Receptor Gamma Modulator CHS-131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis
Nikolaos Perakakis et al.
HEPATOLOGY COMMUNICATIONS (2020)
Sex-based differences in hepatic and skeletal muscle triglyceride storage and metabolism
Kayleigh M. Beaudry et al.
APPLIED PHYSIOLOGY NUTRITION AND METABOLISM (2019)
Chemokine Receptor Redundancy and Specificity Are Context Dependent
Douglas P. Dyer et al.
IMMUNITY (2019)
The effects of metformin on insulin resistance in overweight or obese children and adolescents: A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials
Juan Sun et al.
MEDICINE (2019)
Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism
Takayoshi Sasako et al.
NATURE COMMUNICATIONS (2019)
Proinflammatory NFkB signalling promotes mitochondrial dysfunction in skeletal muscle in response to cellular fuel overloading
Raid B. Nisr et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial
Yanislava Karusheva et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2019)
Oral Semaglutide Versus Empagliflozin in Patients With Type 2 Diabetes Uncontrolled on Metformin: The PIONEER 2 Trial
Helena W. Rodbard et al.
DIABETES CARE (2019)
β Cell dysfunction during progression of metabolic syndrome to type 2 diabetes
Laura Hudish et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
The Role of Ceramides in Insulin Resistance
Emilia Sokolowska et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1
Hui Yan et al.
DIABETES (2019)
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes
Kenneth Cusi et al.
DIABETES OBESITY & METABOLISM (2019)
The integrative biology of type 2 diabetes
Michael Roden et al.
NATURE (2019)
Effect of a Dual PPAR α/γ agonist on Insulin Sensitivity in Patients of Type 2 Diabetes with Hypertriglyceridemia- Randomized double-blind placebo-controlled trial
Nimisha Jain et al.
SCIENTIFIC REPORTS (2019)
Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis
Maria Apostolopoulou et al.
DIABETES CARE (2018)
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
Scott L. Friedman et al.
HEPATOLOGY (2018)
Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers
Midori Honma et al.
INTERNATIONAL JOURNAL OF OBESITY (2018)
Effect of fibrates on glycemic parameters: A systematic review and meta-analysis of randomized placebo-controlled trials
Luis E. Simental-Mendia et al.
PHARMACOLOGICAL RESEARCH (2018)
INTERORGAN METABOLIC CROSSTALK IN HUMAN INSULIN RESISTANCE
Sofiya Gancheva et al.
PHYSIOLOGICAL REVIEWS (2018)
Pharmacokinetics of the Oral Selective CXCR2 Antagonist AZD5069: A Summary of Eight Phase I Studies in Healthy Volunteers
Marie Cullberg et al.
DRUGS IN R&D (2018)
ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P
Ju Youn Kim et al.
CELL (2018)
Acute dietary fat intake initiates alterations in energy metabolism and insulin resistance
Elisa Alvarez Hernandez et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk
Allison B. Goldfine et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness
Yong-ho Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2017)
Inflammation, metaflammation and immunometabolic disorders
Gokhan S. Hotamisligil
NATURE (2017)
Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance
Ruth C. R. Meex et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance
Max C. Petersen et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Sodium-Glucose Co-transporters and Their Inhibition: Clinical Physiology
Ele Ferrannini
CELL METABOLISM (2017)
Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production
Paul M. Titchenell et al.
CELL METABOLISM (2016)
Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy
A. Dutour et al.
DIABETES OBESITY & METABOLISM (2016)
The role of macrophages in obesity-driven chronic liver disease
Lindsey Devisscher et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Regulation of mTORC1 by growth factors, energy status, amino acids and mechanical stimuli at a glance
Peter Bond
JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION (2016)
Energy Balance After Sodium-Glucose Cotransporter 2 Inhibition
Giulia Ferrannini et al.
DIABETES CARE (2015)
Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III study
J. Miyagawa et al.
DIABETES OBESITY & METABOLISM (2015)
Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus
Hideaki Jinnouchi et al.
JOURNAL OF DIABETES RESEARCH (2015)
Sex-specific differences in lipid and glucose metabolism
Oleg Varlamov et al.
FRONTIERS IN ENDOCRINOLOGY (2015)
Tuberous Sclerosis Complex 1-Mechanistic Target of Rapamycin Complex 1 Signaling Determines Brown-to-White Adipocyte Phenotypic Switch
Xinxin Xiang et al.
DIABETES (2015)
Protein Ingestion Induces Muscle Insulin Resistance Independent of Leucine-Mediated mTOR Activation
Gordon I. Smith et al.
DIABETES (2015)
CXC Chemokines Function as a Rheostat for Hepatocyte Proliferation and Liver Regeneration
Gregory C. Wilson et al.
PLOS ONE (2015)
Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance
Byung-Cheol Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma-associated adverse cardiac effects
Remy Hanf et al.
DIABETES & VASCULAR DISEASE RESEARCH (2014)
Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
Aurora Merovci et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
Kathleen M. Dungan et al.
LANCET (2014)
Regulation of mTORC1 by amino acids
Liron Bar-Peled et al.
TRENDS IN CELL BIOLOGY (2014)
Branched-Chain and Aromatic Amino Acids Are Predictors of Insulin Resistance in Young Adults
Peter Wurtz et al.
DIABETES CARE (2013)
Efficacy and Safety of Lixisenatide Once-Daily Morning or Evening Injections in Type 2 Diabetes Inadequately Controlled on Metformin (GetGoal-M)
Bo Ahren et al.
DIABETES CARE (2013)
Dual Peroxisome Proliferator-Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
Bertrand Cariou et al.
DIABETES CARE (2013)
Anti-inflammatory cytokines and risk of type 2 diabetes
C. Herder et al.
DIABETES OBESITY & METABOLISM (2013)
Evaluation of inflammatory and angiogenic factors in patients with non-alcoholic fatty liver disease
Stephanie Coulon et al.
CYTOKINE (2012)
Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase
Saswata Talukdar et al.
NATURE MEDICINE (2012)
Insulin stimulation of SREBP-1c processing in transgenic rat hepatocytes requires p70 S6-kinase
Joshua L. Owen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Inflammatory Mechanisms in Obesity
Margaret F. Gregor et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Postprandial Hepatic Lipid Metabolism Requires Signaling through Akt2 Independent of the Transcription Factors FoxA2, FoxO1, and SREBP1c
Min Wan et al.
CELL METABOLISM (2011)
Akt Stimulates Hepatic SREBP1c and Lipogenesis through Parallel mTORC1-Dependent and Independent Pathways
Jessica L. Yecies et al.
CELL METABOLISM (2011)
FoxO Feedback Control of Basal IRS-2 Expression in Pancreatic β-Cells Is Distinct From That in Hepatocytes
Shin Tsunekawa et al.
DIABETES (2011)
MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
Harold E. Bays et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
PKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans
Olivier Bezy et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Inflammatory links between obesity and metabolic disease
Carey N. Lumeng et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Endoplasmic reticulum stress in liver disease
Harmeet Malhi et al.
JOURNAL OF HEPATOLOGY (2011)
Chronic TNF-α Neutralization Does Not Improve Insulin Resistance or Endothelial Function in Healthy Men with Metabolic Syndrome
Thomas C. Wascher et al.
MOLECULAR MEDICINE (2011)
Tuberous Sclerosis Complex-1 Deficiency Attenuates Diet-Induced Hepatic Lipid Accumulation
Heidi L. Kenerson et al.
PLOS ONE (2011)
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease
Naoki Kumashiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The role of metformin and thiazolidinediones in the regulation of hepatic glucose metabolism and its clinical impact
Esther Phielix et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
The Effect of Branched Chain Amino Acids on Skeletal Muscle Mitochondrial Function in Young and Elderly Adults
Laura L. Tatpati et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis
Shijie Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
CXC Ligand 5 Is an Adipose-Tissue Derived Factor that Links Obesity to Insulin Resistance
Carine Chavey et al.
CELL METABOLISM (2009)
Endoplasmic Reticulum Stress Is Reduced in Tissues of Obese Subjects After Weight Loss
Margaret F. Gregor et al.
DIABETES (2009)
CCR2 Promotes Hepatic Fibrosis in Mice
Ekihiro Seki et al.
HEPATOLOGY (2009)
Inhibitory effect of IL-8 on insulin action in human adipocytes via MAP kinase pathway
Chikaaki Kobashi et al.
JOURNAL OF INFLAMMATION-LONDON (2009)
Meta-analysis: Metformin treatment in persons at risk for diabetes mellitus
Shelley R. Salpeter et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Selective versus total insulin resistance: A pathogenic paradox
Michael S. Brown et al.
CELL METABOLISM (2008)
Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease
Puneet Puri et al.
GASTROENTEROLOGY (2008)
Endoplasmic Reticulum Stress Markers Are Associated with Obesity in Nondiabetic Subjects
Neeraj K. Sharma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Guadalupe Sabio et al.
SCIENCE (2008)
Activation of peroxisome proliferator-activated receptor (PPAR)δ promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatly acid oxidation in moderately obese men
Ulf Riserus et al.
DIABETES (2008)
Adipocyte death, adipose tissue remodeling, and obesity complications
Katherine J. Strissel et al.
DIABETES (2007)
Miglitol increases the adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitus
Hiroki Yokoyama et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Prevalence of non-alcoholic fatty liver disease: population based study
Deepak Amarapurkar et al.
ANNALS OF HEPATOLOGY (2007)
Visceral fat adipokine secretion is associated with systemic inflammation in obese humans
Luigi Fontana et al.
DIABETES (2007)
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review
A Natali et al.
DIABETOLOGIA (2006)
Efficacy of glimepiride on insulin resistance, adipocytokines, and atherosclerosis
Kunihiko Koshiba et al.
JOURNAL OF MEDICAL INVESTIGATION (2006)
Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability
F Tremblay et al.
DIABETES (2005)
Therapeutic roles of peroxisome proliferator-activated receptor agonists
B Staels et al.
DIABETES (2005)
SREBPs suppress IRS-2-mediated insulin signalling in the liver
T Ide et al.
NATURE CELL BIOLOGY (2004)
Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
VT Samuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Insulin down-regulates insulin receptor substrate-2 expression through the phosphatidylinositol 3-kinase/Akt pathway
Y Hirashima et al.
JOURNAL OF ENDOCRINOLOGY (2003)
Glimepiride improves both first and second phases of insulin secretion in type 2 diabetes
M Korytkowski et al.
DIABETES CARE (2002)
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes
N Musi et al.
DIABETES (2002)
Gene expression of tumor necrosis factor α and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients
J Crespo et al.
HEPATOLOGY (2001)
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of IKKβ
MS Yuan et al.
SCIENCE (2001)
Insulin inhibits transcription of IRS-2 gene in rat liver through an insulin response element (IRE) that resembles IREs of other insulin-repressed genes
JD Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser(307) via distinct pathways
LY Rui et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
分享论文
